Randomized phase III trial of cisplatin + TS-1 [S 1] versus cisplatin + docetaxel regimens for stage IIIB/IV non-small cell lung carcinoma.
Phase of Trial: Phase III
Latest Information Update: 12 May 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Docetaxel
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Acronyms CATS
- 02 Oct 2012 Final analysis presented at the 37th Congress of the European Society for Medical Oncology.
- 06 Jun 2012 Status changed from active, no longer recruiting to completed.
- 06 Jun 2012 Results were reported at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), and in a Taiho Pharmaceutical media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History